Masayuki Fukumura

Tsu, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Trajectories and determinants of respiratory syncytial virus prefusion F-specific IgG in older adults.

Trajectories and determinants of respiratory syncytial virus prefusion F-specific IgG in older adults.

Journal: BMC infectious diseases
Published: December 16, 2025

Temporal trends in RSV-specific antibody seroprevalence among hosptalized children during the COVID-19 pandemic in Japan: a retrospective cross-sectional study.

Temporal trends in RSV-specific antibody seroprevalence among hosptalized children during the COVID-19 pandemic in Japan: a retrospective cross-sectional study.

Journal: BMC infectious diseases
Published: November 12, 2025

Next Generation RNA/Protein-Carrying Vector With Pleiotropic Activity.

Next Generation RNA/Protein-Carrying Vector With Pleiotropic Activity.

Journal: Reviews in medical virology
Published: February 09, 2024

Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis.

Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis.

Journal: Nature communications
Published: May 31, 2021

Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2.

Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2.

Journal: iScience
Published: February 24, 2021

A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis.

A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis.

Journal: Nature communications
Published: June 06, 2019

A versatile platform technology for recombinant vaccines using non-propagative human parainfluenza virus type 2 vector.

A versatile platform technology for recombinant vaccines using non-propagative human parainfluenza virus type 2 vector.

Journal: Scientific reports
Published: October 09, 2018

Nucleocytoplasmic shuttling of the human parainfluenza virus type 2 phosphoprotein.

Nucleocytoplasmic shuttling of the human parainfluenza virus type 2 phosphoprotein.

Journal: Virology
Published: August 20, 2018

Human parainfluenza virus type 2 vector induces dendritic cell maturation without viral RNA replication/transcription.

Human parainfluenza virus type 2 vector induces dendritic cell maturation without viral RNA replication/transcription.

Journal: Human gene therapy
Published: June 25, 2013
Showing 1-9 of 9

Last Updated: 09/26/2026